Humana Insured Patients: Loyola Medicine is out of network with Humana. Humana is re-engaged in negotiations to reach a fair agreement. Learn more loyolamedicine.org/humana.

Ronald K Potkul

Ronald K Potkul, MD

Gynecologic Oncology, Obstetrics & Gynecology

Provider Groups

  • Loyola Medicine Physician

  • Loyola Physician Partners

Primary Contact

888-584-7888
Appointments (New Patients Welcome)
Provider Groups
  • Loyola Medicine Physician

  • Loyola Physician Partners

Primary Contact
888-584-7888

Services & Specialties

Areas of Specialization

  • Gynecologic Oncology
  • Obstetrics & Gynecology

Clinical Interests

Conditions Treated

  • sentinel lymph node biopsy
  • cervical and endometrial cancer surgery
  • cervical and endometrial cancers
  • Complex Pelvic Surgery
  • Vaginal Cancer
  • gestational trophoblastic disease
  • minimally invasive gynecologic surgery
  • ovarian cancer
  • ovarian cancer surgery
  • Robotic Gynecological Surgery
  • gynecologic cancer surgery
  • vulvar cancer
  • leiomyosarcoma
  • paget's disease of vulva
  • radical vulvectomy
Show more

Locations & Contact

Primary Location

Loyola University Medical Center

2160 S First Ave
Maywood, IL 60153

View hours
Monday
8:00am - 5:00pm
Tuesday
8:00am - 5:00pm
Wednesday
8:00am - 5:00pm
Thursday
8:00am - 5:00pm
Friday
8:00am - 5:00pm
Saturday
8:00am - 5:00pm
Sunday
8:00am - 5:00pm
Loyola University Medical Center

About

Academic Title

Professor

Leadership Title

Department Chairperson, Obstetrics and Gynecology

Ages Seen

Adults - Over 65
Adults - 18 to 64

Additional Resources

Education & Certifications

Education

Education:
University of Chicago Pritzker School of Medicine (1981)

Internship:
University of Chicago Medical Center (1982)

Residency:
University of Chicago Medical Center (1985)

Fellowship:
Georgetown University Hospital (1988)

Board Certifications

Gynecologic Oncology, Gynecologic Oncology, American Board of Obstetrics & Gynecology Subspecialty (1990)

Gynecologic Oncology, Gynecologic Oncology, American Board of Obstetrics and Gynecology Subspecialty (1990)

Provider Groups

Loyola Medicine Physician

Loyola Physician Partners

Provider Ratings

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn More >

4.8 out of 5

(172 ratings)

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

37 Reviews

04/01/2025

Excellent as well.

04/01/2025

This visit was a follow up from surgery. I was impressed with everyone on Dr. Potkul's team!

03/28/2025

Dr. Potkul is so kind and gentle. He really cares about his patients

03/25/2025

I trust him completely

03/18/2025

He is a very good dr

03/07/2025

My experience has been very good except for the issue with the surgery schedule but that was eventually resolved. the surgery experience was very successful overall.

02/28/2025

I'm just thankful to God for sending me to Loyola under Dr. Potkul care and the family of Loyola University Cardinal Center, thank you with all my heart.

02/18/2025

Dr. Potkul is thorough and thoughtful at every visit.

02/04/2025

I鈥檓 very pleased with all my visits there

01/28/2025

Que todos son excelentes

01/28/2025

Solo me resta decir que estoy muy agradecida y feliz por los resultados sobre mi salud gracias a los cuidados del Dr Potkul

12/27/2024

I would reccommend anyone to go to Dr. Potkul and his Great Staff

12/27/2024

I was referred to Dr. Potkul by my surgeon at Elmhurst Hospital. I'm so glad she sent me here.

12/17/2024

I have been a clinical dietitian working in health for over 40 years. I know a good provider when i meet one.

12/10/2024

keep up the welcoming spirit, you are all great !

11/26/2024

Great doctor; great staff

11/26/2024

As stated earlier, caring, impeccable bedside manner, and just caring and comforting

11/22/2024

Dr Potkul as usual was comforting, explained medical terms with patience and thorough.

11/08/2024

Dr. Potkul is exceptional. Very caring and very knowledgeable. I wouldn鈥檛 have any other Doctor taking care of me.

11/05/2024

Dr. Potkul is excellent at making me comfortable during an uncomfortable exam.

10/08/2024

Buena calidad y profesionalidad

10/04/2024

The entire vibe from the moment a patient walks into the Cardinal Bernadine Cancer Center iOS very positive.

09/27/2024

The doctor and staff made a very nervous patient, me have a caring professional experience.

09/27/2024

I never felt that anyone hurried to get to the next patient.

09/24/2024

Pues si me gusto como me.atendieron

09/17/2024

Everyone is so friendly and professional.

09/17/2024

I had a great experience with my doctors and staff.

09/13/2024

Superior in every detail

09/10/2024

He is outstanding. I'm fortunate to be under hos care.

09/03/2024

thank you to Dr. Potkul. He has removed my cancer and my treatments are working to keep the cancer away

08/30/2024

As I mentioned in previous feedback entry, Dr Potkul is wonderful, personable, and superb. Helps makes my situation, hopeful.

08/30/2024

God bless Dr Potkul and staff

08/16/2024

Continuar con la misma calidad de servicio gracias

07/30/2024

He will answer any questions you have and he is very caring.

07/30/2024

Very good care

07/30/2024

I have been seeing him for many years now with treatments for cancer.

06/28/2024

Highly regarded
Show more

Publications

  • Cabozantinib inhibits tumor growth in mice with ovarian cancer. Stiff, P. J.; Kertowidjojo, E.; Potkul, R. K.; Banerjee, S.; Mehrotra, S.; Small, W.; Stack, M. S.; Drakes, M. L.; American journal of cancer research
  • Evaluating outcomes and toxicities for a newly implemented MRI-based brachytherapy program for cervical cancer. Ross, D. H.; Gomez, K.; Harmon, G.; Mysz, M. L.; Shea, S. M.; Goldberg, A.; Liotta, M.; Potkul, R.; Winder, A.; Lee, B.; Jackson, J.; Roeske, J. C.; Small, W.; Harkenrider, M. M.; Gynecologic oncology
  • Selinexor in Combination with Decitabine Attenuates Ovarian Cancer in Mice. Stiff, P. J.; Mehrotra, S.; Potkul, R. K.; Banerjee, S.; Walker, C.; Drakes, M. L.; Cancers
  • Initial Experience with the Radiotracer 18F-Fluciclovine PET/CT in Ovarian Cancer. Buehner, T. M.; Liotta, M.; Potkul, R. K.; Wagner, R. H.; Savir-Baruch, B.; Molecular imaging and biology
  • Uterine perforation during brachytherapy for cervical cancer: Complications, outcomes, and best practices for forward treatment planning and management. Small, W.; Kim, Y. S.; Joyce, C.; Surucu, M.; Leshyk, M.; Harkenrider, M. M.; Potkul, R. K.; Liotta, M.; Winder, A.; Altoos, B.; Brachytherapy
  • Repurposing Kir6/SUR2 Channel Activator Minoxidil to Arrests Growth of Gynecologic Cancers. Fukushiro-Lopes, D.; Hegel, A. D.; Russo, A.; Senyuk, V.; Liotta, M.; Beeson, G. C.; Beeson, C. C.; Burdette, J.; Potkul, R. K.; Gentile, S.; Frontiers in pharmacology
  • Salvage treatment in recurrent endometrial cancer of the pelvis and peritoneal cavity. McAlarnen, L. A.; Ryan, K.; Adams, W.; Gliniewicz, A.; Winder, A. D.; Liotta, M. R.; Potkul, R. K.; Small, W.; Harkenrider, M. M.; Gynecologic oncology reports
  • Does adjuvant concurrent or sequential chemotherapy increase the radiation-related toxicity of vaginal brachytherapy for endometrial cancer patients? Nieto, K.; Martin, B.; Pham, N.; Palmere, L.; Silva, S. R.; Winder, A.; Liotta, M.; Potkul, R. K.; Small, W.; Harkenrider, M. M.; Brachytherapy
  • Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand- 1 (PD-L1) in ovarian cancer. Drakes, M. L.; Mehrotra, S.; Aldulescu, M.; Potkul, R. K.; Liu, Y.; Grisoli, A.; Joyce, C.; O'Brien, T. E.; Stack, M. S.; Stiff, P. J.; Journal of ovarian research
  • Comparison of dosimetric and clinical outcomes between short- and long-channel cylinder applicators for vaginal brachytherapy in intermediate- and high-risk endometrial cancer. Kharouta, M. Z.; Pham, N.; Nieto, K.; Surucu, M.; Mysz, M. L.; Albuquerque, K.; Winder, A.; Liotta, M.; Potkul, R. K.; Small, W.; Harkenrider, M. M.; Brachytherapy
  • Early outcomes and impact of a hybrid IC/IS applicator for a new MRI-based cervical brachytherapy program. Harkenrider, M. M.; Surucu, M.; Harmon, G.; Mysz, M. L.; Shea, S. M.; Yacoub, J.; Goldberg, A.; Liotta, M.; Winder, A.; Potkul, R.; Roeske, J. C.; Small, W.; Brachytherapy
  • Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630. Potkul, R. K.; Unger, J. M.; Livingston, R. B.; Crew, K. D.; Wilczynski, S. P.; Salomon, C. G.; Smith, B. L.; Wong, L.; Campbell, D. L.; Einspahr, D. E.; Anderson, G. L.; Hershman, D.; Goodman, G. E.; Brown, P. H.; Meyskens, F. L.; Albain, K. S.; NPJ breast cancer
  • How one institution overcame the challenges to start an MRI-based brachytherapy program for cervical cancer. Harkenrider, M. M.; Shea, S. M.; Wood, A. M.; Chinsky, B.; Bajaj, A.; Mysz, M.; Yacoub, J. H.; Goldberg, A.; Liotta, M.; Potkul, R.; Surucu, M.; Roeske, J.; Small, W.; Journal of contemporary brachytherapy
  • Fatal case of luteinized thecoma with sclerosing peritonitis in a 40-year-old woman. Bahar, B.; Hu, Z.; Szpaderska, A.; Liotta, M.; Potkul, R. K.; Smith, D.; Erşahin, Ç.; International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT. Albuquerque, K.; Giangreco, D.; Morrison, C.; Siddiqui, M.; Sinacore, J.; Potkul, R.; Roeske, J.; International journal of radiation oncology, biology, physics
  • Hepatic resection for recurrent metastatic ovarian cancer. Abood, G.; Bowen, M.; Potkul, R.; Aranha, G.; Shoup, M.; American journal of surgery
  • FNA diagnosis of retroperitoneal leiomyosarcoma metastasizing to the breast. Omeroglu, G.; Ersşahin, C.; Potkul, R. K.; Booth, C. N.; Diagnostic cytopathology
  • Myeloid sarcoma of the vulva as the presenting symptom in a patient with acute myeloid leukemia. Erşahin, C.; Omeroglu, G.; Potkul, R. K.; Salhadar, A.; Gynecologic oncology
  • Mesonephric adenocarcinoma of the vagina with a 3-year follow-up. Erşahin, C.; Huang, M.; Potkul, R. K.; Hammadeh, R.; Salhadar, A.; Gynecologic oncology
  • Impact of tumor volume-directed involved field radiation therapy integrated in the management of recurrent ovarian cancer. Albuquerque, K. V.; Singla, R.; Potkul, R. K.; Smith, D. M.; Creech, S.; Lo, S.; Emami, B.; Gynecologic oncology
  • Comparison of human papillomavirus type 16 L1 chimeric virus-like particles versus L1/L2 chimeric virus-like particles in tumor prevention. Wakabayashi, M. T.; Da Silva, D. M.; Potkul, R. K.; Kast, W. M.; Intervirology
  • A murine model for the effects of pelvic radiation and cisplatin chemotherapy on human papillomavirus vaccine efficacy. Small, L. A.; Da Silva, D. M.; de Visser, K. E.; Velders, M. P.; Fisher, S. G.; Potkul, R. K.; Kast, W. M.; Clinical cancer research : an official journal of the American Association for Cancer Research
  • Cervical cancer cells induce apoptosis of cytotoxic T lymphocytes. Contreras, D. N.; Krammer, P. H.; Potkul, R. K.; Bu, P.; Rossi, J. L.; Kaufmann, A. M.; Gissmann, L.; Qiao, L.; Journal of immunotherapy (Hagerstown, Md. : 1997)
  • Sonographic assessment of an inaccessible chemotherapy infusion port. Kalbhen, C. L.; Salomon, C. G.; Contreras, D. N.; Smith, D. M.; Potkul, R. K.; AJR. American journal of roentgenology
  • PBLs of early breast carcinoma patients with a high nuclear grade tumor unlike PBLs of cervical carcinoma patients do not show a decreased TCR zeta expression but are functionally impaired. Nieland, J. D.; Loviscek, K.; Kono, K.; Albain, K. S.; McCall, A. R.; Potkul, R. K.; Fisher, S. G.; Velders, M. P.; Petersson, M.; Kiessling, R.; Kast, W. M.; Journal of immunotherapy (Hagerstown, Md. : 1997)
  • A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervix. Irvin, W. P.; Price, F. V.; Bailey, H.; Gelder, M.; Rosenbluth, R.; Durivage, H. J.; Potkul, R. K.; Cancer
  • Regulation of human papillomavirus type 18 in vivo: effects of estrogen and progesterone in transgenic mice. Michelin, D.; Gissmann, L.; Street, D.; Potkul, R. K.; Fisher, S.; Kaufmann, A. M.; Qiao, L.; Schreckenberger, C.; Gynecologic oncology
  • Interferon-gamma enhances susceptibility of cervical cancer cells to lysis by tumor-specific cytotoxic T cells. Street, D.; Kaufmann, A. M.; Vaughan, A.; Fisher, S. G.; Hunter, M.; Schreckenberger, C.; Potkul, R. K.; Gissmann, L.; Qiao, L.; Gynecologic oncology
  • High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients. Stiff, P. J.; Bayer, R.; Kerger, C.; Potkul, R. K.; Malhotra, D.; Peace, D. J.; Smith, D.; Fisher, S. G.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Reply. Delgado, G.; Potkul, R. K.; Gynecologic oncology
  • Paclitaxel is only a weak radiosensitizer of human cervical carcinoma cell lines. Erlich, E.; McCall, A. R.; Potkul, R. K.; Walter, S.; Vaughan, A.; Gynecologic oncology
  • The variation of inguinal lymph node depth in adult women and its importance in planning elective irradiation for vulvar cancer. McCall, A. R.; Olson, M. C.; Potkul, R. K.; Cancer
  • Retroperitoneal radical hysterectomy. Delgado, G.; Potkul, R. K.; Dolan, J. R.; Gynecologic oncology
  • Vulvar reconstruction using a mons pubis pedicle flap. Potkul, R. K.; Barnes, W. A.; Barter, J. F.; Delgado, G.; Spear, S. L.; Gynecologic oncology